Browsing publications by Dr James Allan

Newcastle AuthorsTitleYear
Dr Sarah Fordham
Dr Helen Marr
Dr James Allan
Searching for clarity in therapy-related myelodysplastic syndrome/acute myeloid leukemia prognostication2013
Dr Sarah Fordham
Professor Graham Jackson
Dr Simon Bomken
Dr James Allan
A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia2012
Dr Andrea Beyerle
Professor Olaf Heidenreich
Dr James Allan
AML1/ETO Confers a Mutator Phenotype in AML2012
Dr Julie Irving
Dr James Allan
Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia2012
Dr James Allan
Dr Falko Sniehotta
Professor Marie Johnston
Good planners can already plan but poor planners benefit from action plans2012
Dr James Allan
Second Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy2012
Dr Andrea Beyerle
Professor Olaf Heidenreich
Dr James Allan
AML1/ETO Confers a Mutator Phenotype In Acute Myeloid Leukemia Associated with Downregulation of the Base-Excision-Repair Gene OGG12011
Dr Julie Irving
Dr James Allan
DNA mismatch repair status affects cellular response to Ara-C and other anti-leukemic nucleoside analogs2011
Amy Bradburn
Dr James Allan
Professor Olaf Heidenreich
The Angiogenic Factor Angiopoietin-1 Is Regulated by the Acute Myeloid Leukemia Fusion Protein AML1/ETO2011
Professor Graham Jackson
Dr Simon Bomken
Dr James Allan
A Functional Polymorphism In the CD95 Cell Death Receptor Associated with Prognosis In Acute Promyelocytic Leukemia2010
12345